Zuari Agro Chemicals Limited received two interim orders from the Regional Director, Western Region-I, Ministry of Corporate Affairs (MCA), Mumbai, on July 29, 2026. The orders pertain to compounding applications filed under Section 441 of the Companies Act, 2013, addressing alleged non-compliances under Sections 166 and 178 of the Act. The company disclosed that the interim orders do not materially impact its financial position or operational activities. Compounding fees totaling ₹19.50 lakhs were levied across the company and its directors.

The disclosure was made pursuant to Regulation 30 read with Clause 20 of Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The Regional Director passed the interim orders in response to applications submitted by the company along with its Executive Director, Promoter Directors, Directors, and former Directors/KMPs. The violations relate to duties breached by directors during FY20-21 and excess managerial remuneration paid during FY19-20.

Details of Alleged Violations

The interim orders address two specific areas of alleged contravention under the Companies Act, 2013:

Under Section 166, the alleged violation concerns the breach of duties by the company's directors during the financial year 2020-21. Under Section 178, the issue relates to the payment of excess managerial remuneration to Mr. Sunil Sethy, the erstwhile Managing Director, during the financial year 2019-20.

Financial Implications and Fees

The company clarified that no compounding fee was levied directly on Zuari Agro Chemicals Limited under the interim order relating to Section 166. However, a total compounding fee of ₹6.50 lakhs was levied on the Executive Director, Promoter Directors, Directors, and KMPs (including former Directors/KMPs) as specified in the order.

Regarding the Section 178 violation, total compounding fees of ₹13.00 lakhs were levied on the applicants. This amount includes ₹5.00 lakhs levied specifically on the company, with the remainder charged to Promoter Directors and former Directors/KMPs in accordance with the interim order. The combined financial outflow for compounding fees stands at ₹19.50 lakhs.

What the Numbers Show

The allocation of compounding fees reveals a differentiated liability structure between the corporate entity and individual officers. While the company bears a direct financial penalty of ₹5.00 lakhs for the remuneration breach under Section 178, it faces no direct fee for the broader directorial duty breaches under Section 166. Instead, the entire ₹6.50 lakh fee for Section 166 is borne by the individuals involved. This suggests the MCA viewed the Section 178 violation as having a more direct institutional impact warranting corporate liability, whereas the Section 166 breaches were treated primarily as individual directorial failures.

Zuari Agro Chemicals Limited shareholders have approved the appointment of Nitin M. Kantak as Managing Director and Pramod Kumar Gupta as a Non-Executive Non-Independent Director through a postal ballot process. The resolutions were passed on July 23, 2026, the final day of the remote e-voting period, with overwhelming support from promoter groups and significant backing from public non-institutional investors for the MD role. The filing, submitted to the BSE and NSE on July 24, 2026, confirms compliance with Regulation 44(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The scrutinizer, Shivaram Bhat, Practicing Company Secretary (ACS 10454), verified the votes cast via the Central Depository Services (India) Limited (CDSL) platform. The record date for determining shareholder eligibility was June 19, 2026, with 44,576 shareholders on record. The e-voting window remained open from June 24, 2026, at 10:00 A.M. IST to July 23, 2026, at 5:00 P.M. IST. No invalid votes were recorded in any category.

Voting Results Breakdown

The postal ballot sought approval for two distinct resolutions: a special resolution for the appointment of the Managing Director and an ordinary resolution for the appointment of the Non-Executive Director. Below is the detailed voting outcome for each resolution.

Resolution 1: Appointment of Managing Director

This special resolution concerned the appointment of Nitin M. Kantak (DIN: 08029847) as Managing Director and the approval of his remuneration. It received substantial support from promoters and non-institutional public shareholders, though it faced notable opposition from public institutions.

Resolution 2: Appointment of Non-Executive Director

This ordinary resolution concerned the appointment of Pramod Kumar Gupta (DIN: 00064041) as a Non-Executive Non-Independent Director. This resolution saw broader support across all shareholder categories compared to the first resolution, particularly from public institutions.

What the Numbers Show

A divergence in shareholder sentiment is evident between the two resolutions, particularly among public institutional investors. While institutions opposed the appointment of the Managing Director by a margin of 83.35%, they supported the appointment of the Non-Executive Director by 92.32%. This suggests that institutional stakeholders may have specific concerns regarding the executive role or remuneration structure associated with the Managing Director position, while viewing the non-executive board addition favorably. Conversely, non-institutional public shareholders strongly backed the Managing Director appointment (97.86%) but were more divided on the Non-Executive Director appointment (40.60%). The promoter group’s unanimous support for both resolutions ensured passage despite these mixed signals from minority shareholders.